Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial.
Hoegen-Saßmannshausen P, Naumann P, Hoffmeister-Wittmann P, Ben Harrabi S, Seidensaal K, Weykamp F, Mielke T, Ellerbrock M, Habermehl D, Springfeld C, Dill MT, Longerich T, Schirmacher P, Mehrabi A, Chang DH, Hörner-Rieber J, Jäkel O, Haberer T, Combs SE, Debus J, Herfarth K, Liermann J. Hoegen-Saßmannshausen P, et al. Among authors: habermehl d. JHEP Rep. 2024 Mar 11;6(6):101063. doi: 10.1016/j.jhepr.2024.101063. eCollection 2024 Jun. JHEP Rep. 2024. PMID: 38737600 Free PMC article.
[Radiotherapy of hepatic metastases].
Combs SE, Herfarth KK, Habermehl D, Debus J. Combs SE, et al. Among authors: habermehl d. Chirurg. 2010 Jun;81(6):526-32. doi: 10.1007/s00104-010-1889-3. Chirurg. 2010. PMID: 20508910 Review. German.
Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial.
Combs SE, Kieser M, Rieken S, Habermehl D, Jäkel O, Haberer T, Nikoghosyan A, Haselmann R, Unterberg A, Wick W, Debus J. Combs SE, et al. Among authors: habermehl d. BMC Cancer. 2010 Sep 6;10:478. doi: 10.1186/1471-2407-10-478. BMC Cancer. 2010. PMID: 20819220 Free PMC article. Clinical Trial.
Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial.
Combs SE, Burkholder I, Edler L, Rieken S, Habermehl D, Jäkel O, Haberer T, Haselmann R, Unterberg A, Wick W, Debus J. Combs SE, et al. Among authors: habermehl d. BMC Cancer. 2010 Oct 6;10:533. doi: 10.1186/1471-2407-10-533. BMC Cancer. 2010. PMID: 20925951 Free PMC article. Clinical Trial.
Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: the MARCIE trial.
Combs SE, Edler L, Burkholder I, Rieken S, Habermehl D, Jäkel O, Haberer T, Unterberg A, Wick W, Debus J, Haselmann R. Combs SE, et al. Among authors: habermehl d. BMC Cancer. 2010 Nov 9;10:615. doi: 10.1186/1471-2407-10-615. BMC Cancer. 2010. PMID: 21062428 Free PMC article. Clinical Trial.
Assessment of early toxicity and response in patients treated with proton and carbon ion therapy at the Heidelberg ion therapy center using the raster scanning technique.
Rieken S, Habermehl D, Nikoghosyan A, Jensen A, Haberer T, Jäkel O, Münter MW, Welzel T, Debus J, Combs SE. Rieken S, et al. Among authors: habermehl d. Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e793-801. doi: 10.1016/j.ijrobp.2010.12.018. Epub 2011 Feb 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 21300464
118 results